NVAX peer analysis
Novavax (NVAX) against its competitors: price, today's move, 1-year return and market value side by side.
- NVAX's peers: ARCT (Arcturus), BNTX (BioNTech), EBS (Emergent BioSolutions), GOVX (GeoVax Labs), INO (Inovio Pharmaceuticals), MRNA (Moderna), OGEN (Oragenics), PCVX (Vaxcyte).
NVAX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARCT Arcturus | $7.55 | -0.66% | 25.00% | $217.61M |
| BNTX BioNTech | $81.00 | -0.47% | -20.14% | $20.08B |
| EBS Emergent BioSolutions | $5.12 | -0.58% | -48.23% | $263.25M |
| GOVX GeoVax Labs | $1.55 | -18.85% | -99.38% | $652.48K |
| INO Inovio Pharmaceuticals | $1.84 | 7.60% | 3.37% | $127.13M |
| MRNA Moderna | $199.30 | -0.02% | 724.23% | $80.64B |
| OGEN Oragenics | $0.17 | -8.99% | -82.77% | $776.06K |
| PCVX Vaxcyte | $55.72 | -4.52% | 14.60% | $8.82B |
| SCNI Scinai Immunotherapeutics | $1.40 | -9.92% | -96.46% | $180.93K |
| VALN Valneva | $5.37 | 0.47% | -38.33% | $510.36M |
| NVAX Novavax | $7.55 | -2.20% | 19.09% | $1.25B |